InScope – December 2022: Letter from physician leaders

December 14, 2022 Providence inScope Content Team

Dear Colleague,

As we approach the end of 2022, please know how much we value and appreciate the care and compassion you provide every day to your patients. Providers serve as the backbone of Providence’s commitment to exceptional patient care, and we are very grateful for you.

Although providers and care teams continue to weather many challenges – COVID and its ongoing variants, flu and RSV, and nationwide financial challenges affecting health care – you have never wavered in your commitment to your patients and communities. Together, we will continue to work through these challenges.

If you are a Providence employed or affiliated provider, thank you for living the Providence Mission every day. If you are a community physician, we are honored that you entrust your patients to Providence when you refer care to one of our specialists or facilities – thank you.

We wish a happy and safe holiday season to you, your families and colleagues.

Gratefully,

Elizabeth Ransom, M.D., FACS
Chief Medical Officer
Providence Central Division

Kevin Olson, M.D.
Chief Executive
Providence Central Division
Institutes and Programs

Ben LeBlanc, M.D.
Chief Executive, Providence Medical Group

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.
More Content by Providence inScope Content Team

Welcome to your journey for creating a healthier you

InScope – December 2022: Letter from physician leaders

About the Author

Previous Article

Next Article

InScope – December 2022: Letter from physician leaders

About the Author

Previous Article

Next Article

Most Recent Articles

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).